Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 16 de 16
Filtrar
1.
Blood ; 119(14): 3321-9, 2012 Apr 05.
Artículo en Inglés | MEDLINE | ID: mdl-22323447

RESUMEN

Synthetic triterpenoids are multitarget compounds exhibiting promise as preventative and therapeutic agents for cancer. Their proposed mechanism of action is by forming Michael adducts with reactive nucleophilic groups on target proteins. Our previous work demonstrates that the 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) and its derivatives promote B-lymphoid cell apoptosis through a mitochondria-mediated pathway linked to mitochondrial protein aggregation. As one function of the Lon protease is to eliminate abnormal mitochondrial proteins, we hypothesized that CDDO-induced protein aggregation and lymphoma apoptosis occur by inactivating this enzyme. Here, we show that CDDO and its derivatives directly and selectively inhibit Lon. CDDO blocks Lon-mediated proteolysis in biochemical and cellular assays, but does not inhibit the 20S proteasome. Furthermore, a biotinylated-CDDO conjugate modifies mitochondrial Lon. A striking common phenotype of CDDO-treated lymphoma cells and Lon-knockdown cells is the accumulation of electron-dense aggregates within mitochondria. We also show that Lon protein levels are substantially elevated in malignant lymphoma cells, compared with resting or activated B cells. Finally, we demonstrate that Lon knockdown leads to lymphoma cell death. Together, these findings suggest that Lon inhibition plays a contributory role in CDDO-induced lymphoma cell death, and support the concept that mitochondrial Lon is a novel anticancer drug target.


Asunto(s)
Linfoma/enzimología , Mitocondrias/enzimología , Ácido Oleanólico/análogos & derivados , Proteasa La/metabolismo , Línea Celular , Supervivencia Celular/efectos de los fármacos , Supervivencia Celular/genética , Activación Enzimática/efectos de los fármacos , Técnicas de Silenciamiento del Gen , Humanos , Cuerpos de Inclusión/efectos de los fármacos , Cuerpos de Inclusión/metabolismo , Cuerpos de Inclusión/ultraestructura , Linfoma/genética , Linfoma de Células B/genética , Linfoma de Células B/metabolismo , Mitocondrias/efectos de los fármacos , Mitocondrias/ultraestructura , Ácido Oleanólico/síntesis química , Ácido Oleanólico/metabolismo , Ácido Oleanólico/farmacología , Proteasa La/antagonistas & inhibidores , Proteasa La/genética , Complejo de la Endopetidasa Proteasomal/efectos de los fármacos , Unión Proteica , Regulación hacia Arriba
2.
Biochim Biophys Acta ; 1777(7-8): 651-9, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18515063

RESUMEN

In this work we provide evidence for the potential presence of a potassium channel in skeletal muscle mitochondria. In isolated rat skeletal muscle mitochondria, Ca(2+) was able to depolarize the mitochondrial inner membrane and stimulate respiration in a strictly potassium-dependent manner. These potassium-specific effects of Ca(2+) were completely abolished by 200 nM charybdotoxin or 50 nM iberiotoxin, which are well-known inhibitors of large conductance, calcium-activated potassium channels (BK(Ca) channel). Furthermore, NS1619, a BK(Ca)-channel opener, mimicked the potassium-specific effects of calcium on respiration and mitochondrial membrane potential. In agreement with these functional data, light and electron microscopy, planar lipid bilayer reconstruction and immunological studies identified the BK(Ca) channel to be preferentially located in the inner mitochondrial membrane of rat skeletal muscle fibers. We propose that activation of mitochondrial K(+) transport by opening of the BK(Ca) channel may be important for myoprotection since the channel opener NS1619 protected the myoblast cell line C2C12 against oxidative injury.


Asunto(s)
Calcio/farmacología , Mitocondrias Musculares/fisiología , Músculo Esquelético/fisiología , Canales de Potasio/fisiología , Partículas Submitocóndricas/fisiología , Animales , Bencimidazoles/farmacología , Línea Celular , Caribdotoxina/farmacología , Membranas Intracelulares/efectos de los fármacos , Membranas Intracelulares/fisiología , Potenciales de la Membrana/efectos de los fármacos , Potenciales de la Membrana/fisiología , Mitocondrias Musculares/efectos de los fármacos , Canales de Potasio/efectos de los fármacos , Ratas , Partículas Submitocóndricas/efectos de los fármacos
3.
Int J Mol Sci ; 10(3): 1104-20, 2009 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-19399240

RESUMEN

The mitochondrial response to changes of cytosolic calcium concentration has a strong impact on neuronal cell metabolism and viability. We observed that Ca(2+) additions to isolated rat brain mitochondria induced in potassium ion containing media a mitochondrial membrane potential depolarization and an accompanying increase of mitochondrial respiration. These Ca(2+) effects can be blocked by iberiotoxin and charybdotoxin, well known inhibitors of large conductance potassium channel (BK(Ca) channel). Furthermore, NS1619 - a BK(Ca) channel opener - induced potassium ion-specific effects on brain mitochondria similar to those induced by Ca(2+). These findings suggest the presence of a calcium-activated, large conductance potassium channel (sensitive to charybdotoxin and NS1619), which was confirmed by reconstitution of the mitochondrial inner membrane into planar lipid bilayers. The conductance of the reconstituted channel was 265 pS under gradient (50/450 mM KCl) conditions. Its reversal potential was equal to 50 mV, which proved that the examined channel was cation-selective. We also observed immunoreactivity of anti-beta(4) subunit (of the BK(Ca) channel) antibodies with ~26 kDa proteins of rat brain mitochondria. Immunohistochemical analysis confirmed the predominant occurrence of beta(4) subunit in neuronal mitochondria. We hypothesize that the mitochondrial BK(Ca) channel represents a calcium sensor, which can contribute to neuronal signal transduction and survival.


Asunto(s)
Encéfalo/metabolismo , Calcio/farmacología , Mitocondrias/efectos de los fármacos , Canales de Potasio/metabolismo , Potasio/metabolismo , Animales , Anticuerpos/inmunología , Inmunohistoquímica , Iones/química , Subunidades alfa de los Canales de Potasio de Gran Conductancia Activados por Calcio , Masculino , Potencial de la Membrana Mitocondrial/efectos de los fármacos , Mitocondrias/metabolismo , Péptidos/farmacología , Bloqueadores de los Canales de Potasio/farmacología , Canales de Potasio/química , Canales de Potasio/inmunología , Subunidades de Proteína/química , Subunidades de Proteína/inmunología , Subunidades de Proteína/metabolismo , Ratas , Ratas Wistar , Transducción de Señal/efectos de los fármacos
4.
Methods Mol Biol ; 1990: 143-149, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31148069

RESUMEN

Redox signaling in the cell, which is essential for cell physiology, involves proteins with free sulfhydryl groups (-SH). Among them, the thioredoxin system plays the most significant role. Many conditions associated with cell malignancies feature the higher expression of thioredoxin, making it an attractive target for new therapeutic drug development. Here we present a simple in vitro model of testing the interaction between thioredoxin and the putative drug. This method is relatively inexpensive and gives the Investigator a first screen of the drug properties, which can be essential for further experimental approaches.


Asunto(s)
Técnicas In Vitro/métodos , Maleimidas/química , Polietilenglicoles/química , Especies Reactivas de Oxígeno/metabolismo , Compuestos de Sulfhidrilo/química , Tiorredoxinas/química , Humanos , Maleimidas/metabolismo , Oxidación-Reducción , Compuestos de Sulfhidrilo/metabolismo , Tiorredoxinas/metabolismo
5.
Biochim Biophys Acta ; 1757(5-6): 715-20, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16787636

RESUMEN

Mitochondrial potassium channels, such as ATP-regulated or large conductance Ca2+ -activated and voltage gated channels were implicated in cytoprotective phenomenon in different tissues. Basic effects of these channels activity include changes in mitochondrial matrix volume, mitochondrial respiration and membrane potential, and generation of reactive oxygen species. In this paper, we describe the pharmacological properties of mitochondrial potassium channels and their modulation by channel inhibitors and potassium channel openers. We also discuss potential side effects of these substances.


Asunto(s)
Mitocondrias/fisiología , Canales de Potasio/fisiología , Adenosina Trifosfato/metabolismo , Animales , Calcio/metabolismo , Humanos , Activación del Canal Iónico , Potenciales de la Membrana/efectos de los fármacos , Mitocondrias/efectos de los fármacos , Bloqueadores de los Canales de Potasio/farmacología , Canales de Potasio/agonistas , Canales de Potasio Calcio-Activados/agonistas , Canales de Potasio Calcio-Activados/antagonistas & inhibidores , Canales de Potasio con Entrada de Voltaje/agonistas , Canales de Potasio con Entrada de Voltaje/antagonistas & inhibidores
6.
Postepy Biochem ; 52(2): 137-44, 2006.
Artículo en Polaco | MEDLINE | ID: mdl-17078503

RESUMEN

Ion channels are proteins, which facilitate the ions flow throught biological membranes. In recent years the structure as well as the function of the plasma membrane ion channels have been well investigated. The knowledge of intracellular ion channels however is still poor. Up till now, the calcium channel described in endoplasmatic reticulum and mitochondrial porine are the examples of intracellular ion channels, which have been well characterized. The mitochondrial potassium channels: regulated by ATP (mitoK(ATP)) and of big conductance activated by Ca2+ (mitoBK(Ca)), which were described in inner mitochondrial membrane, play a key role in the protection of heart muscle against ischemia. In this review the last date concerning the mitochondrial ion channels as well as they function in cell metabolism have been presented.


Asunto(s)
Activación del Canal Iónico/fisiología , Canales Iónicos/metabolismo , Potenciales de la Membrana/fisiología , Mitocondrias/fisiología , Membranas Mitocondriales/metabolismo , Adenosina Trifosfato/metabolismo , Animales , Canales de Calcio/metabolismo , Señalización del Calcio/fisiología , Canales de Cloruro/metabolismo , Canales de Potasio/metabolismo , Canales de Potasio Calcio-Activados/metabolismo , Canales de Potasio con Entrada de Voltaje/metabolismo , Canales de Sodio/metabolismo
7.
Biochim Biophys Acta ; 1556(2-3): 97-105, 2002 Dec 02.
Artículo en Inglés | MEDLINE | ID: mdl-12460666

RESUMEN

We have investigated the presence of diazoxide- and nicorandil-activated K+ channels in rat skeletal muscle. Activation of potassium transport in the rat skeletal muscle myoblast cell line L6 caused a stimulation of cellular oxygen consumption, implying a mitochondrial effect. Working with isolated rat skeletal muscle mitochondria, both potassium channel openers (KCOs) stimulate respiration, depolarize the mitochondrial inner membrane and lead to oxidation of the mitochondrial NAD-system in a strict potassium-dependent manner. This is a strong indication for KCO-mediated stimulation of potassium transport at the mitochondrial inner membrane. Moreover, the potassium-specific effects of both diazoxide and nicorandil on oxidative phosphorylation in skeletal muscle mitochondria were completely abolished by the antidiabetic sulfonylurea derivative glibenclamide, a well-known inhibitor of ATP-regulated potassium channels (K(ATP) channels). Since both diazoxide and nicorandil facilitated swelling of de-energised mitochondria in KSCN buffer at the same concentrations, our results implicate the presence of a mitochondrial ATP-regulated potassium channel (mitoK(ATP) channel) in rat skeletal muscle which can modulate mitochondrial oxidative phosphorylation.


Asunto(s)
Mitocondrias Musculares/metabolismo , Músculo Esquelético/metabolismo , Mioblastos/metabolismo , Canales de Potasio/metabolismo , Animales , Antiarrítmicos/farmacología , Línea Celular , Respiración de la Célula/fisiología , Diazóxido/farmacología , Ácido Glutámico/metabolismo , Gliburida/farmacología , Malatos/metabolismo , Potenciales de la Membrana/fisiología , Mitocondrias Musculares/efectos de los fármacos , Músculo Esquelético/citología , Músculo Esquelético/efectos de los fármacos , Mioblastos/efectos de los fármacos , Nicorandil/farmacología , Oxidación-Reducción , Oxígeno/metabolismo , Ratas
8.
Br J Pharmacol ; 145(6): 785-91, 2005 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-15895111

RESUMEN

Antidiabetic sulphonylureas can bind to various intracellular organelles including mitochondria. The aim of this study was to monitor the influence of antidiabetic sulphonylureas on membrane permeability in mitochondria isolated from rat skeletal muscle. The effects of glibenclamide (and other sulphonylurea derivatives) on mitochondrial function were studied by measuring mitochondrial swelling, mitochondrial membrane potential, respiration rate and Ca2+ transport into mitochondria. We observed that glibenclamide induced mitochondrial swelling (EC50 = 8.2 +/- 2.5 microM), decreased the mitochondrial membrane potential and evoked Ca2+ efflux from the mitochondrial matrix. These effects were blocked by 2 microM cyclosporin A, an inhibitor of the mitochondrial permeability transition. Moreover, 30 microM glibenclamide accelerated the respiratory rate in the presence of glutamate/malate, substrates of complex I of the mitochondrial respiratory chain. In conclusion, we postulate that the antidiabetic sulphonylureas activate the mitochondrial permeability transition in skeletal muscle by increasing its sensitivity to Ca2+.


Asunto(s)
Calcio/metabolismo , Gliburida/farmacología , Hipoglucemiantes/farmacología , Mitocondrias Musculares/efectos de los fármacos , Permeabilidad/efectos de los fármacos , Animales , Ciclosporina/farmacología , Glipizida/farmacología , Técnicas In Vitro , Potenciales de la Membrana/efectos de los fármacos , Mitocondrias Musculares/metabolismo , Mitocondrias Musculares/fisiología , Dilatación Mitocondrial/efectos de los fármacos , Músculo Esquelético/efectos de los fármacos , Oxígeno/metabolismo , Ratas , Compuestos de Sulfonilurea/farmacología
9.
Exp Hematol ; 43(2): 89-99, 2015 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-25448488

RESUMEN

B-cell malignancies are a common type of cancer. One approach to cancer therapy is to either increase oxidative stress or inhibit the stress response systems on which cancer cells rely. In this study, we combined nontoxic concentrations of Auranofin (AUR), an inhibitor of the thioredoxin system, with nontoxic concentrations of buthionine-sulfoximine (BSO), a compound that reduces intracellular glutathione levels, and investigated the effect of this drug combination on multiple pathways critical for malignant B-cell survival. Auranofin interacted synergistically with BSO at low concentrations to trigger death in multiple malignant B-cell lines and primary mantle-cell lymphoma cells. Additionally, there was less toxicity toward normal B cells. Low AUR concentrations inhibited thioredoxin reductase (TrxR) activity, an effect significantly increased by BSO cotreatment. Overexpression of TrxR partially reversed AUR+BSO toxicity. Interestingly, the combination of AUR+BSO inhibited nuclear factor κB (NF-κB) signaling. Moreover, synergistic cell death induced by this regimen was attenuated in cells overexpressing NF-κB proteins, arguing for a functional role for NF-κB inhibition in AUR+BSO-mediated cell death. Together, these findings suggest that AUR+BSO synergistically induces malignant B-cell death, a process mediated by dual inhibition of TrxR and NF-κB, and such an approach warrants further investigation in B-cell malignancies.


Asunto(s)
Antimetabolitos/farmacología , Antineoplásicos/farmacología , Auranofina/farmacología , Linfocitos B/efectos de los fármacos , Butionina Sulfoximina/farmacología , Regulación Neoplásica de la Expresión Génica , Linfocitos B/metabolismo , Linfocitos B/patología , Muerte Celular/efectos de los fármacos , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Sinergismo Farmacológico , Glutatión/antagonistas & inhibidores , Glutatión/metabolismo , Humanos , Linfoma de Células del Manto/tratamiento farmacológico , Linfoma de Células del Manto/genética , Linfoma de Células del Manto/metabolismo , Linfoma de Células del Manto/patología , Terapia Molecular Dirigida , FN-kappa B/antagonistas & inhibidores , FN-kappa B/genética , FN-kappa B/metabolismo , Oxidación-Reducción , Estrés Oxidativo/efectos de los fármacos , Cultivo Primario de Células , Transducción de Señal , Reductasa de Tiorredoxina-Disulfuro/antagonistas & inhibidores , Reductasa de Tiorredoxina-Disulfuro/genética , Reductasa de Tiorredoxina-Disulfuro/metabolismo , Tiorredoxinas/antagonistas & inhibidores , Tiorredoxinas/genética , Tiorredoxinas/metabolismo
10.
Biochem Pharmacol ; 65(11): 1827-34, 2003 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-12781334

RESUMEN

Recently, it has been reported that large-conductance Ca(2+)-activated potassium channels, also known as BK(Ca)-type potassium channels, are present in the inner mitochondrial membrane of the human glioma LN229 cell line. Hence, in the present study, we have investigated whether BK(Ca)-channel openers (BK(Ca)COs), such as the benzimidazolone derivatives NS004 (5-trifluoromethyl-1-(5-chloro-2-hydroxyphenyl)-1,3-dihydro-2H-benzimidazole-2-one) and NS1619 (1,3-dihydro-1-[2-hydroxy-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-2H-benzimidazol-2-one), affect the functioning of LN229 glioma cell mitochondria in situ. We examined the effect of BK(Ca)COs on mitochondrial membrane potential, mitochondrial respiration and plasma membrane potassium current in human glioma cell line LN229. We found that BK(Ca)COs decrease the mitochondrial membrane potential with an EC(50) value of 3.6+/-0.4 microM for NS1619 and 5.4+/-0.8 microM for NS004. This mitochondrial depolarization was accompanied by an inhibition of the mitochondrial respiratory chain. Both BK(Ca)COs induced whole-cell potassium current blocked by charybdotoxin, as measured by the patch-clamp technique. The BK(Ca)COs had no effect on membrane bilayer conductance. Moreover, the inhibition of mitochondrial function by NS004 and NS1619 was without effect on cell survival, as measured by lactate dehydrogenase release from the cells.


Asunto(s)
Bencimidazoles/farmacología , Clorofenoles/farmacología , Mitocondrias/efectos de los fármacos , Canales de Potasio/agonistas , Caribdotoxina/farmacología , Glioma , Humanos , Potenciales de la Membrana/efectos de los fármacos , Mitocondrias/fisiología , Técnicas de Placa-Clamp , Canales de Potasio/fisiología , Células Tumorales Cultivadas
11.
Toxicol Mech Methods ; 14(1-2): 63-5, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-20021125

RESUMEN

Mitochondria play a central role in energy generation within the cell. Since the discovery of potassium channels in the inner mitochondrial membrane, mitochondria have been considered an important target for potassium channel openers. The purpose of this short review is to present the recent state of our knowledge about big-conductance potassium channels (BK-type channels) recently discovered in the inner mitochondrial membrane. In addition, modulation of mitochondrial functions by the BK-type potassium channel openers are described.

12.
Methods Enzymol ; 474: 149-64, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20609909

RESUMEN

In recent years, the importance of compartmentalization in redox signaling has been realized. A number of specific thiol pools exist both inside and outside the cell, and these thiols are regulated via unique mechanisms and serve specific roles in cell signaling. This chapter covers some of the methodologies available for the interrogation of thiol status in various cellular compartments, with a focus on mitochondrial, cytosolic, and exofacial thiols. Finally, the relevance of these thiols to pathological disease states, in particular cancer, will be discussed. The chapters in the remainder of this volume more than adequately cover the diversity of thiol modifications, describing the specific biochemical nature of these reactions, ranging from S-nitrosation through glutathionylation, to oxidation and beyond. Therefore, this topic will not be further addressed here. Similarly, general methodological considerations are considered to have been dealt with in the remainder of this volume, including requirements for subdued lighting, avoidance of reducing agents and transition metals in media, and rapid sample preparation with adequate control over temperature and pH.


Asunto(s)
Citosol/química , Espacio Extracelular/química , Proteínas/análisis , Compuestos de Sulfhidrilo/análisis , Animales , Células Cultivadas , Glutatión/análisis , Glutatión/química , Humanos , Mitocondrias/química , Mitocondrias/enzimología , Oxidación-Reducción , Proteínas/química , Compuestos de Sulfhidrilo/química
13.
Front Biosci (Landmark Ed) ; 14(4): 1197-218, 2009 01 01.
Artículo en Inglés | MEDLINE | ID: mdl-19273125

RESUMEN

Mitochondria are central to energy metabolism as the source of much of the cell's ATP, as well as being a hub for cellular Ca2+ signaling. Mitochondrial Ca2+ is a positive effector of ATP synthesis, yet Ca2+ overload can lead to mitochondrial dysfunction and cell death. Moreover, Ca2+ uptake by mitochondria is involved in shaping cellular Ca2+ dynamics by regulating the concentrations of Ca2+ within microdomains between mitochondria and sarco/endoplasmic reticulum and plasma membrane Ca2+ transporters. Reactive oxygen species (ROS) generated as a consequence of ATP production in the mitochondria are important for cellular signaling, yet contribute to oxidative stress and cellular damage. ROS regulate the activity of redox sensitive enzymes and ion channels within the cell, including Ca2+ channels. For both Ca2+ and ROS, a delicate balance exists between the beneficial and detrimental effects on mitochondria. In this review we bring together current data on mitochondrial Ca2+ uptake, ROS generation, and redox modulation of Ca2+ transport proteins. We present a model for crosstalk between Ca2+ and ROS signaling pathways within mitochondrial microdomains.


Asunto(s)
Calcio/metabolismo , Mitocondrias/metabolismo , Especies Reactivas de Oxígeno/metabolismo , Receptor Cross-Talk , Transducción de Señal , Animales , Ratones
14.
Mitochondrion ; 9(3): 204-10, 2009 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-19460290

RESUMEN

The Complex I NADH dehydrogenase-ubiquinone-FeS 4 (NDUFS4) subunit gene is involved in proper Complex I function such that the loss of NDUFS4 decreases Complex I activity resulting in mitochondrial disease. Therefore, a mouse model harboring a point mutation in the NDUFS4 gene was created. An embryonic lethal phenotype was observed in homozygous (NDUFS4(-/-)) mutant fetuses. Mitochondrial function was impaired in heterozygous animals based on oxygen consumption, and Complex I activity in NDUFS4 mouse mitochondria. Decreased Complex I activity with unaltered Complex II activity, along with an accumulation of lactate, were consistent with Complex I disorders in this mouse model.


Asunto(s)
Modelos Animales de Enfermedad , Complejo I de Transporte de Electrón/deficiencia , Enfermedades Mitocondriales/genética , Enfermedades Mitocondriales/patología , Mutación Puntual , Animales , Complejo I de Transporte de Electrón/genética , Femenino , Heterocigoto , Homocigoto , Ratones , Ratones Endogámicos C57BL , Ratones Endogámicos ICR
15.
PLoS One ; 4(12): e8115, 2009 Dec 02.
Artículo en Inglés | MEDLINE | ID: mdl-19956548

RESUMEN

BACKGROUND: There has been much interest in targeting intracellular redox pathways as a therapeutic approach for cancer. Given recent data to suggest that the redox status of extracellular protein thiol groups (i.e. exofacial thiols) effects cell behavior, we hypothesized that redox active anti-cancer agents would modulate exofacial protein thiols. METHODOLOGY/PRINCIPAL FINDINGS: To test this hypothesis, we used the sesquiterpene lactone parthenolide, a known anti-cancer agent. Using flow cytometry, and western blotting to label free thiols with Alexa Fluor 633 C(5) maleimide dye and N-(biotinoyl)-N-(iodoacetyl) ethylendiamine (BIAM), respectively, we show that parthenolide decreases the level of free exofacial thiols on Granta mantle lymphoma cells. In addition, we used immuno-precipitation techniques to identify the central redox regulator thioredoxin, as one of the surface protein thiol targets modified by parthenolide. To examine the functional role of parthenolide induced surface protein thiol modification, we pretreated Granta cells with cell impermeable glutathione (GSH), prior to exposure to parthenolide, and showed that GSH pretreatment; (a) inhibited the interaction of parthenolide with exofacial thiols; (b) inhibited parthenolide mediated activation of JNK and inhibition of NFkappaB, two well established mechanisms of parthenolide activity and; (c) blocked the cytotoxic activity of parthenolide. That GSH had no effect on the parthenolide induced generation of intracellular reactive oxygen species supports the fact that GSH had no effect on intracellular redox. Together these data support the likelihood that GSH inhibits the effect of parthenolide on JNK, NFkappaB and cell death through its direct inhibition of parthenolide's modulation of exofacial thiols. CONCLUSIONS/SIGNIFICANCE: Based on these data, we postulate that one component of parthenolide's anti-lymphoma activity derives from its ability to modify the redox state of critical exofacial thiols. Further, we propose that cancer cell exofacial thiols may be important and novel targets for therapy.


Asunto(s)
Membrana Celular/metabolismo , Sesquiterpenos/farmacología , Compuestos de Sulfhidrilo/metabolismo , Antioxidantes/farmacología , Western Blotting , Muerte Celular/efectos de los fármacos , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Ensayos de Selección de Medicamentos Antitumorales , Activación Enzimática/efectos de los fármacos , Espacio Extracelular/efectos de los fármacos , Espacio Extracelular/metabolismo , Citometría de Flujo , Glutatión/farmacología , Humanos , Proteínas Quinasas JNK Activadas por Mitógenos/metabolismo , Linfoma/enzimología , Linfoma/patología , FN-kappa B/antagonistas & inhibidores , Tiorredoxinas/metabolismo
16.
Postepy Hig Med Dosw ; 56(3): 315-21, 2002.
Artículo en Polaco | MEDLINE | ID: mdl-12194244

RESUMEN

Ion channels selective for potassium or chloride ions are present in inner mitochondrial membranes. They are probably important in cellular events such as regulation of organelle volume changes. Additionally, mitochondrial potassium channels are targets for potassium channel openers and antidiabetic sulfonylureas. This review describes properties, and current hypotheses concerning the functional role of mitochondrial ion channels.


Asunto(s)
Canales Iónicos/metabolismo , Mitocondrias/metabolismo , Adenosina Trifosfato/metabolismo , Canales de Cloruro/metabolismo , Canales Iónicos/efectos de los fármacos , Mitocondrias/efectos de los fármacos , Canales de Potasio/metabolismo , Compuestos de Sulfonilurea/farmacología , Vesículas Sinápticas/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA